XBiotech Inc (XBIT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $59.76M
Last updated: Nov 17, 2026 at 4:10 PM ET
XBiotech Inc (XBIT) Statistics
XBiotech (XBIT) has a market cap of $59.76M. It holds $105.04M more cash than debt, 175.78% of its market cap.
Total Valuation
| Market Cap | $59.76M |
|---|---|
| Latest price (Nov 17, 2026) | $1.78 |
Key Dates
The next earnings report is expected on Mar 11, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 11, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 32.58% over 52 weeks and trades 14.01% below its 50-day average.
| Beta (1Y) | 0.50 |
|---|---|
| 52-Week Change | -32.58% |
| 1-Month Change | -11.00% |
| 3-Month Change | -22.94% |
| 6-Month Change | -24.89% |
| 5-Year Change | -87.18% |
| 10-Year Change | -85.81% |
| Total Return (1Y) | -32.58% |
| Total Return (3Y CAGR) | -22.37% |
| Total Return (5Y CAGR) | -32.77% |
| Return vs SPY (1Y) | -35.81% |
| Max Drawdown (1Y) | -34.32% |
| Max Drawdown (3Y) | -82.00% |
| Sharpe Ratio (1Y) | -0.76 |
| Correlation with SPY (1Y) | 0.19 |
| 50-Day Average | $2.07 |
| 200-Day Average | $2.28 |
| 52-Week Range | $1.80 to $2.73 |
| RSI (14 Days) | 33.4 |
| Average Volume (20 Days) | 78.01K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 39.51x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 39.51x |
|---|---|
| Quick Ratio | 39.51x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -35.13% over the last 12 months, against a 5-year average of -16.99%.
| Return on Equity (ROE) | -35.13% |
|---|---|
| Return on Assets (ROA) | -33.89% |
| ROE (5Y Average) | -16.99% |
| ROA (5Y Average) | -16.05% |
| ROIC (5Y Average) | -19.73% |
Scores
XBIT has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Gross Profit | -$378.00K |
| Operating Income | -$47.49M |
| Pretax Income | -$43.38M |
| Net Income | -$43.59M |
| Reported EPS (TTM) | -$1.43 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 96.46% of the $128.61M in total assets.
| Cash and Equivalents | $105.04M |
|---|---|
| Total Debt | $0 |
| Net Cash | $105.04M |
| Net Cash Per Share | $3.45 |
| Working Capital | $103.66M |
| Shareholder Equity | $124.06M |
| Book Value Per Share | $4.07 |
| Total Assets | $128.61M |
| Total Liabilities | $4.55M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$40.96M |
|---|---|
| FCF Per Share | -$1.34 |
| Depreciation and Amortization | $1.26M |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | -19.98% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | -19.98% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About XBIT
What is XBIT's market cap?
XBiotech has a market cap of $59.76M.
How many shares of XBIT are outstanding?
XBiotech has 30.49M shares outstanding. The count is up 0.00% from a year earlier.
Does XBIT pay a dividend?
No. XBiotech does not pay a dividend.
How much debt does XBIT have?
XBiotech has $0 of total debt and $105.04M of cash and equivalents, a net cash position of $105.04M.
XBIT pages: Overview, Charting, Earnings, Financials, Statistics, Competitors